The Cambridge genomics spinout has secured $5.4m in additional series A funding from drug maker Taiho Pharmaceutical.

The autonomous driving software developer, which also counts Nvidia as a backer, raised new funding from investors including Robert Bosch, Cisco and Samsung.

The strategic alliance will officially launch a $200m mobility-focused corporate venturing fund tomorrow at electronics trade show CES.

University of Birmingham Enterprise will handle tech transfer activities, manage the $7m Spinout Investment Fund and handle a range of incubation and training services.

Swarm64, a data analytics software producer founded at Humboldt University of Berlin, has raised $12.5m in a round that was co-led by Intel Capital.

Rewind Therapeutics, which is developing therapies for myelin-related diseases like MS, secured $18.3m in a Boehringer Ingelheim and Merck Group-backed round.

Data analytics software producer Swarm64 has raised $12.5m in a round that was co-led by Intel Capital, taking its total funding to more than $21m.

The KU Leuven spinout is researching remedies for debilitating diseases of the nervous system such as multiple sclerosis.

Novartis Venture Fund co-led a $20.3m round for Oculis, which is developing a topical liquid that can be applied to diseases at the back of the eye.